NK-1 receptor antagonists anesthesia recovery

The present invention is directed to the administration of a compound of the Formula (I) and (Ia), wherein R2 is selected from the group consisting of methyl, ethyl, isopropyl, sec-butyl and tert-butyl, to an animal to improve anesthesia recovery

Saved in:
Bibliographic Details
Main Authors MISKELL, CHRISTINE, EDNA, HICKMAN, MARY, ANNE
Format Patent
LanguageEnglish
Published 28.11.2007
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to the administration of a compound of the Formula (I) and (Ia), wherein R2 is selected from the group consisting of methyl, ethyl, isopropyl, sec-butyl and tert-butyl, to an animal to improve anesthesia recovery
Bibliography:Application Number: ZA20060005149